rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression — Stella

Recruiting

Back to Depression, Treatment Resistant trials

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

Trial locations(1 site)

United States

Goodman Hall Neuroscience Center, Indianapolis, Indiana

Key details

Sponsor

Indiana University

Collaborators

National Center for Advancing Translational Sciences (NCATS)

Enrollment target

~20 participants

Started

January 2024

Primary completion

June 2026

Age range

18 Years – 70 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov